Vimarsana
Biggest News Aggregation in the World

40kmph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 40kmph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 40kmph Today - Breaking & Trending Today

Eastern Peripheral Expressway Delhi and its 120 kmph speed limit - Vimarsana News

Eastern Peripheral Expressway Delhi and its 120 kmph speed limit

This is an absolutely wrong argument to make that we don't have the right cars for the stipulated speed limit. Fact is EPE is not a smooth highway at all. It is littered with undulations, dips and

EVs that can do 350 - 400 km of highway running, at 120 kmph and some hill climbs - Vimarsana News

EVs that can do 350 - 400 km of highway running, at 120 kmph and some hill climbs

I found EVs like the EV6 to be very compelling products. One requirement in my mind is that it should be able to travel from Bangalore to Ooty on a single charge. This would be ~350km and include

New Delhi to airport now in 15 minutes, Metro to run at 120 kmph from Sunday | Latest News Delhi - Vimarsana News

New Delhi to airport now in 15 minutes, Metro to run at 120 kmph from Sunday | Latest News Delhi

Delhi Metro to operate the Airport Express Line at 120 kmph from Sunday, bringing a reduction in travel time. | Latest News Delhi

StockNews.com Initiates Coverage on Zevra Therapeutics (NASDAQ:KMPH) - Vimarsana News

StockNews.com Initiates Coverage on Zevra Therapeutics (NASDAQ:KMPH)

StockNews.com started coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Stock Performance Zevra Therapeutics has a 52-week low of $4.00 and a 52-week high of $6.92. The firm has […]

StockNews.com Begins Coverage on Zevra Therapeutics (NASDAQ:KMPH) - Vimarsana News

StockNews.com Begins Coverage on Zevra Therapeutics (NASDAQ:KMPH)

StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Price Performance Zevra Therapeutics has a one year low of $4.00 and a one year high of $6.92. The company has a […]